Pulmonary Hypertension in Congenital Heart Disease: Beyond Eisenmenger Syndrome
- PMID: 26471823
- DOI: 10.1016/j.ccl.2015.07.003
Pulmonary Hypertension in Congenital Heart Disease: Beyond Eisenmenger Syndrome
Abstract
Patients with adult congenital heart disease have an increased risk of developing pulmonary hypertension. There are several mechanisms of pulmonary hypertension in patients with adult congenital heart disease, and understanding them requires a systematic approach to define the patient's hemodynamics and physiology. This article reviews the updated classification of pulmonary hypertension in patients with adult congenital heart disease with a focus on pathophysiology, diagnostics, and the evaluation of pulmonary hypertension in special adult congenital heart disease populations.
Keywords: Adult congenital heart disease; Humans vasodilator agents/diagnostic use/therapeutic use; Pulmonary arterial hypertension disease management; Pulmonary hypertension.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Clinical evaluation and management of pulmonary hypertension in the adult with congenital heart disease.Circulation. 2015 Jan 13;131(2):200-10. doi: 10.1161/CIRCULATIONAHA.114.006976. Circulation. 2015. PMID: 25583054 No abstract available.
-
[Pulmonary hypertension associated with congenital heart disease and Eisenmenger syndrome].Arch Cardiol Mex. 2015 Jan-Mar;85(1):32-49. doi: 10.1016/j.acmx.2014.11.008. Epub 2015 Jan 30. Arch Cardiol Mex. 2015. PMID: 25650280 Review. Spanish.
-
Pulmonary hypertension in congenital heart disease.Future Cardiol. 2018 Jul;14(4):343-353. doi: 10.2217/fca-2017-0065. Epub 2018 May 24. Future Cardiol. 2018. PMID: 29792339 Free PMC article. Review.
-
[Pulmonary hypertension in congenital heart disease].Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S322-4. doi: 10.1055/s-2006-957202. Dtsch Med Wochenschr. 2006. PMID: 17139597 Review. German.
-
[Pulmonary arterial hypertension in adult patients with congenital heart disease].Pediatr Med Chir. 2010 Nov-Dec;32(6):274-9. Pediatr Med Chir. 2010. PMID: 21462449 Italian.
Cited by
-
Bodily isomerism is an independent risk factor for pulmonary hypertension in adults with congenital heart disease.Ther Adv Respir Dis. 2016 Jun;10(3):194-9. doi: 10.1177/1753465816636810. Epub 2016 Mar 4. Ther Adv Respir Dis. 2016. PMID: 26944361 Free PMC article.
-
Role of phosphodiesterase-3 inhibitor in cardiorespiratory fitness and functional class of patients with pulmonary hypertension: A randomized, double-blind, placebo-controlled trial.Narra J. 2025 Apr;5(1):e1301. doi: 10.52225/narra.v5i1.1301. Epub 2025 Jan 30. Narra J. 2025. PMID: 40352196 Free PMC article. Clinical Trial.
-
Metformin added to bosentan therapy in patients with pulmonary arterial hypertension associated with congenital heart defects: a pilot study.ERJ Open Res. 2018 Aug 22;4(3):00060-2018. doi: 10.1183/23120541.00060-2018. eCollection 2018 Jul. ERJ Open Res. 2018. PMID: 30151369 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical